Diagnostic chain operator Thyrocare Technologies has made a spectacular debut in stock markets today, rising as much as 49 per cent to Rs 665 on the National Stock Exchange. The diagnostic chain operator had issued shares at Rs 446 in its initial public offer (IPO), which closed on April 29th.
Thyrocare Technologies Ltd. is a healthcare service provider. It owns and operates chain of clinical diagnostic centres in India. It offers testing services, disorder testing, and report tracking services. The firm offers its services to corporate houses, hospitals laboratories and doctors. The company was incorporated in 2000 and is based in Mumbai, Maharashtra with additional offices in Bahrain, Nepal and Bangladesh.
Thyrocare CEO A Velumani has told a leading bisiness channel today that the company wants to open 20 more testing labs across the country in next 2 years with an invest of Rs.3-4 crore per lab.
Thyrocare Technologies Ltd. is a healthcare service provider. It owns and operates chain of clinical diagnostic centres in India. It offers testing services, disorder testing, and report tracking services. The firm offers its services to corporate houses, hospitals laboratories and doctors. The company was incorporated in 2000 and is based in Mumbai, Maharashtra with additional offices in Bahrain, Nepal and Bangladesh.
EXCL A Velumani, Chairman, MD, Thyrocare: Expect sales growth of over 35% in the next 3-4 years. https://t.co/H90MW48f1R— CNBC-TV18 News (@CNBCTV18News) May 9, 2016
Thyrocare CEO A Velumani has told a leading bisiness channel today that the company wants to open 20 more testing labs across the country in next 2 years with an invest of Rs.3-4 crore per lab.
